Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity.
Halliday M, Radford H, Sekine Y, Moreno J, Verity N, le Quesne J, Ortori CA, Barrett DA, Fromont C, Fischer PM, Harding HP, Ron D, Mallucci GR. · 2015
Read Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. by Halliday M, Radford H, Sekine Y, Moreno J, Verity N, le Quesne J, Ortori CA, Barrett DA, Fromont C, Fischer PM, Harding HP, Ron D, Mallucci GR. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4385927.txt.
Description
M. Halliday and a team of co-authors tested a small molecule against prion disease in mice, in Cell Death and Disease in 2015. When misfolded proteins jam the cell's folding compartment, a stress response shuts down protein production. In prion disease that shutdown persists, starving neurons of vital proteins until synapses fail. An earlier drug that lifted the shutdown protected the brain but poisoned the pancreas, which needs the stress response. The team tried ISRIB, which restores production further down the same chain.
ISRIB gave partial restoration of protein synthesis, enough to protect neurons in prion-diseased mice. Crucially, the pancreas showed no harm this time. The separation of benefit from toxicity matters: the stress response is essential in secretory tissues, so any therapy must tune it, not abolish it. Precise tuning downstream offers a safer route.
Catalog record
| CREATOR | Halliday M, Radford H, Sekine Y, Moreno J, Verity N, le Quesne J, Ortori CA, Barrett DA, Fromont C, Fischer PM, Harding HP, Ron D, Mallucci GR. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |